SUVRETTA CAPITAL MANAGEMENT, LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 104 filers reported holding XENON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
SUVRETTA CAPITAL MANAGEMENT, LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$21,154,000
-2.1%
692,0000.0%0.65%
+54.2%
Q4 2021$21,618,000
+22.1%
692,000
-40.3%
0.42%
+40.6%
Q3 2021$17,709,000
+60.1%
1,158,961
+95.1%
0.30%
+80.6%
Q2 2021$11,062,000
+40.4%
594,111
+35.0%
0.16%
+42.2%
Q1 2021$7,877,000440,0640.12%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders